| Similar Articles |
|---|
 |
The Motley Fool
August 5, 2008
Brian Orelli |
No Slowdown for China Medical The great Chinese crash of 2008 hasn't yet hit China Medical Technologies.   |
The Motley Fool
June 10, 2008
Brian Orelli |
Third Wave's Invader Gets Invaded Hologic picks up a promising technology as the diagnostic-testing market picks up steam. |
The Motley Fool
June 27, 2008
Brian Orelli |
The Right Time to Raise Capital After seeing its stock double in less than a month, thanks to some stellar preliminary results from its prenatal Down syndrome test, diagnostic-test maker Sequenom figured now was a perfect time to get some money into the coffers. |
The Motley Fool
February 6, 2008
Brian Orelli |
Insatiable Illumina Revenue is way up at Illumina, but can the company keep it going looking forward? |
The Motley Fool
June 20, 2008
Brian Orelli |
Live From Bio: Personalized Medicine The movement is chugging along thanks to diagnostics. |
The Motley Fool
August 29, 2007
Billy Fisher |
China Medical Continues to Impress China Medical Technologies, the Chinese medical device maker, produces another quarter of incredible growth, which the company attributes to momentum from its in-vitro diagnostic business. |
The Motley Fool
August 19, 2004
Charly Travers |
Myriad's Making Hope Possible This small biotech provides screens that can help catch cancer. Even with solid growth of product revenue, losses could continue to increase as Myriad moves more drugs into clinical development while it transitions into a drug developer. |
The Motley Fool
July 25, 2007
Brian Orelli |
Shiny Happy Illumina Illumina, which makes chips that can distinguish one million different genes, announced another stellar quarter. That makes eight in a row. |
The Motley Fool
July 9, 2008
Brian Lawler |
Predicting More Good News From Invitrogen Invitrogen gets a positive review from the FDA for one of its tests. |
The Motley Fool
January 27, 2009
Brian Orelli |
Testing a Recession-Resistant Hypothesis Quest Diagnostic looks poised for growth even in bad times. |
Managed Care
June 2006 |
Excessive Use of Screening Tests Costs System Millions Each Year Managed care always couched its emphasis on prevention with the caveat that diagnostic tests should be conducted according to generally accepted national practice guidelines. A new study seems to indicate just how costly preventive medicine can be when not tied to a disciplined approach. |
American Family Physician
August 15, 2002 |
Allergy Testing What is allergy testing?... What kinds of allergy tests are available?... Why should I be tested for allergies? |
Health
March 2007
Melanie Haiken |
Is Your Fertility Window Closing? Ticking biological clocks have spawned egg-counting tests. Be wary. |
The Motley Fool
August 6, 2008
Brian Orelli |
Illumina Grabs Some Cash With biochip maker Illumina hitting 52-week highs, it seems inevitable that the company would do a secondary offering to grab some cash -- about $300 million, as it turns out. |
The Motley Fool
September 24, 2008
Brian Orelli |
100% Results From Sequenom The company presents more data on its molecular diagnostic and buys a lab to run the tests in. |
The Motley Fool
July 26, 2007
Brian Orelli |
Affymetrix Advances New products and services should help Affymetrix regain market share. Yesterday, the company even announced a small second-quarter profit. |
T.H.E. Journal
December 2001
Rob Foshay |
Testing, Testing -- Does Anybody Know Why? The purpose of all testing should be to help instructors improve their teaching and to help learners progress. Yet, all too often, that seems to be the least important purpose for tests. The author, an officer of a testing company, shows how his product can help... |
The Motley Fool
December 30, 2008
Brian Orelli |
A Post-Holiday Breakup ... of Sorts Abbott and Celera revise their partnership. |
Chemistry World
September 11, 2013
Emma Stoye |
Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research. |
Bio-IT World
March 2006
Michael A. Greeley |
The Theranostics Promise A huge amount of discovery and clinical development for new drugs involves clinical trials that include companion diagnostic tests. These theranostic tests are poised to become a promising market for entrepreneurs, though challenges -- such as patent issues -- remain. |
Science News
February 2, 2008 |
Science Safari: Be a Cognitive-Test Subject A new website tests your cognitive abilities for research. |
The Motley Fool
October 25, 2007
Brian Orelli |
Turnaround at Affymetrix Affymetrix announces it is continuing its turnaround from an abysmal 2006 with another strong quarter. |
The Motley Fool
October 24, 2007
Brian Orelli |
Illumina's Illuminating Results There was stellar revenue growth, but margins and stock compensations pulled the bottom line down. |
Chemistry World
April 2, 2014
Megan Tyler |
DVD diagnostics A pregnancy test based on standard DVD technology has the potential to be turned into a diagnostic platform that screens for abnormal pregnancies or even testicular cancer. |
The Motley Fool
April 24, 2008
Brian Orelli |
Illumina Ignites This biochip maker is on fire. |
The Motley Fool
February 13, 2006
W.D. Crotty |
China Medical Technologies Soars Cayman Islands-based China Medical Technologies reports strong third-quarter results. However, there are warnings signs for investors to consider. |
Chemistry World
November 21, 2013
Phillip Broadwith |
Rapid DNA sequencing cleared for the clinic The approval covers Illumina's MiSeqDx instrument, together with two diagnostic assay kits for cystic fibrosis that run on it, and a kit that allows clinical labs to develop their own diagnostic tests. |
PC Magazine
September 4, 2007
Loyd Case |
Benchmark-Test Confusion Here, the tricky ins and outs of benchmark tests are explained to computer users. |
The Motley Fool
August 24, 2007
Brian Orelli |
Take Your Medicine; Earn Your Profits Personalized medicine offers investment ideas. Let's take a look at what this new catchphrase in the medical community actually means, and how investors can benefit from it. |
The Motley Fool
April 25, 2008
Brian Orelli |
Affymetrix Learns About Inertia Slower sales of its older chips drag down growth. |
Chemistry World
January 8, 2013
Andrew Turley |
Illumina investment push Gene sequencing company Illumina has struck a $450 million deal to buy privately owned US firm Verinata Health, which specializes in non-invasive tests for early identification of fetal chromosomal abnormalities. |
InternetNews
October 27, 2004
Paul Shread |
Technical Analysis: Techs Break Out And the Dow and S&P take out some important levels too. |
Bio-IT World
February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
T.H.E. Journal
September 2004
Sue Cooper |
Computerized Practice Tests Boost Student Achievement By taking practice tests four to five times prior to the state testing, students are showing significant improvement within their deficit areas. More important, the students are enjoying themselves. |
Job Journal
September 23, 2007
Carole Kanchier |
Personality Tests Back in Favor Increasingly, companies are giving job candidates personality tests as part of the hiring process. Here's what applicants should look out for when faced with such exams. |
T.H.E. Journal
September 2005 |
Achievement and Performance Series Scantron Corp. has recently integrated its Web-based Achievement and Performance Series products to form a complete solution that will help educators easily manage their benchmark tests, as well as their summative and formative assessments. |
Chemistry World
June 9, 2015
Phillip Broadwith |
Opko deepens diagnostics with $1.5bn lab buyout Healthcare firm Opko is aiming to enhance its position in diagnostic technology by agreeing to buy clinical diagnostics service BioReference Laboratories. |
Wall Street & Technology
June 4, 2009
Greg MacSweeney |
Still Stressed Over Bank Stress Tests Although investors greeted the results of the government's banking stress tests with cheers, were the tests strict enough to help prevent another financial meltdown? |
The Motley Fool
October 24, 2008
Brian Orelli |
Affymetrix Has Trouble Turning Around The problem is that Affymetrix doesn't sell sequencers, and no one seems to want the genome and RNA analyzers that it does sell. |
The Motley Fool
November 12, 2008
Brian Orelli |
Affymetrix Gets Specific The biochip maker announces that it will acquire privately held Panomics for $73 million in cash. |
Wired
October 20, 2008
Sonia Zjawinski |
CSI Kitchen Table -- The Latest Home Test Kits Over-the-counter chemical tests can tell you if your spouse is cheating or if your new home ever doubled as a meth lab. |
T.H.E. Journal
October 2008 |
LS Test Builder by Learning Station Learning Station LS Test Builderprovides an intuitive online environment for educators to create, deliver, and assess standards-based formative practice tests to help students prepare for state-mandated assessments. |
Food Engineering
September 1, 2005
Richard F. Stier |
Do your homework Designing the right type of test for your plant makes all the difference in food safety -- especially since people inside and outside of the food industry sometimes don't understand the concepts of process control and testing as a basic verification activity. |
Managed Care
August 2004
Thomas Morrow |
10,000 Cells on a Chip Signal Start of New Era of Diagnosis Diseases will soon be defined by biochemical pathways and genetic interactions. Biochips may identify patients likely to respond to therapeutic agents. All of this is a big deal for health plans. |
